Stoke Therapeutics SG&A Expense (Quarterly) Analysis

Stoke Therapeutics Inc (STOK)

14.74 -1.07 (-6.77%) USD | NASDAQ | May 23, 16:00

14.74 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	10.22M
December 31, 2023	10.61M
September 30, 2023	10.27M
June 30, 2023	10.23M
March 31, 2023	10.21M
December 31, 2022	9.384M
September 30, 2022	9.944M
June 30, 2022	10.11M
March 31, 2022	9.486M
December 31, 2021	8.724M
September 30, 2021	8.325M
June 30, 2021	7.934M
March 31, 2021	6.914M

Date	Value
December 31, 2020	5.682M
September 30, 2020	5.602M
June 30, 2020	5.044M
March 31, 2020	4.52M
December 31, 2019	3.979M
September 30, 2019	3.324M
June 30, 2019	2.422M
March 31, 2019	2.189M
December 31, 2018	1.538M
September 30, 2018	1.09M
June 30, 2018	1.122M
March 31, 2018	0.66M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.422M

Minimum

Jun 2019

10.61M

Maximum

Dec 2023

7.647M

Average

8.524M

Median

SG&A Expense (Quarterly) Benchmarks